Effect of topiramate and zonisamide on fMRI cognitive networks

Neurology

Volumn 88, Issue 12, 2017, Pages 1165-1171

  Wandschneider, Britta ^a,b   Burdett, Jane ^a,b   Townsend, Lucy ^b   Hill, Andrea ^a,b   Thompson, Pamela J ^a,b   Duncan, John S ^a,b   Koepp, Matthias J ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b EPILEPSY SOCIETY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LEVETIRACETAM; TOPIRAMATE; ZONISAMIDE; ANTICONVULSIVE AGENT; FRUCTOSE; ISOXAZOLE DERIVATIVE; OXYGEN;

ADULT; ANTICONVULSANT THERAPY; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; FOCAL EPILEPSY; FRONTAL LOBE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; FUNCTIONAL NEUROIMAGING; HUMAN; LANGUAGE TEST; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE SCANNER; PARIETAL LOBE; PRIORITY JOURNAL; PSYCHOMETRY; RETROSPECTIVE STUDY; WORKING MEMORY; ANALOGS AND DERIVATIVES; BLOOD; BRAIN; COGNITION DISORDERS; COMPLICATION; DIAGNOSTIC IMAGING; DRUG EFFECTS; EPILEPSIES, PARTIAL; HEMISPHERIC DOMINANCE; IMAGE PROCESSING; LANGUAGE; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING;

ADULT; ANTICONVULSANTS; BRAIN; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; EPILEPSIES, PARTIAL; FEMALE; FRUCTOSE; FUNCTIONAL LATERALITY; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; ISOXAZOLES; LANGUAGE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; OXYGEN; RETROSPECTIVE STUDIES;

EID: 85016170595     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000003736     Document Type: Article

References (27)

1. Arif H, Buchsbaum R, Weintraub D, Pierro J, Resor SR, Hirsch LJ. Patient-reported cognitive side effects of anti-epileptic drugs: predictors and comparison of all commonly used antiepileptic drugs. Epilepsy Behav 2009;14: 202-209.
2. Mula M, Trimble MR. Antiepileptic drug-induced cognitive adverse effects: potential mechanisms and contributing factors. CNS Drugs 2009;23:121-137.
3. Ojemann LM, Ojemann GA, Dodrill CB, Crawford CA, Holmes MD, Dudley DL. Language disturbances as side effects of topiramate and zonisamide therapy. Epilepsy Behav 2001;2:579-584.
4. Jansen JFA, Aldenkamp AP, Marian Majoie HJ, et al. Functional MRI reveals declined prefrontal cortex activation in patients with epilepsy on topiramate therapy. Epilepsy Behav 2006;9:181-185.
5. Szaflarski JP, Allendorfer JB. Topiramate and its effect on fMRI of language in patients with right or left temporal lobe epilepsy. Epilepsy Behav 2012;24:74-80.
6. De Ciantis A, Muti M, Piccolini C, et al. A functional MRI study of language disturbances in subjects with migraine headache during treatment with topiramate. Neurol Sci 2008;29(suppl 1):S141-S143.
7. Yasuda CL, Centeno M, Vollmar C, et al. The effect of topiramate on cognitive fMRI. Epilepsy Res 2013;105: 250-255.
8. Tang Y, Xia W, Yu X, et al. Altered cerebral activity associated with topiramate and its withdrawal in patients with epilepsy with language impairment: an fMRI study using the verb generation task. Epilepsy Behav 2016;59: 98-104.
9. Kwon O-Y, Park S-P. Zonisamide decreases current-source density of high beta frequency of electroencephalogram. J Epilepsy Res 2013;3:63-69.
10. Wandschneider B, Stretton J, Sidhu M, et al. Levetirace-tam reduces abnormal network activations in temporal lobe epilepsy. Neurology 2014;83:1508-1512.
11. Lieberman MD, Cunningham WA. Type I, type II error concerns in fMRI research: re-balancing the scale. Soc Cogn Affect Neurosci 2009;4:423-428.
12. Wilke M, Lidzba K. LI-tool: a new toolbox to assess lat-eralization in functional MR-data. J Neurosci Methods 2007;163:128-136.
13. Baxendale S, Thompson PJ, Duncan JS. Improvements in memory function following anterior temporal lobe resection for epilepsy. Neurology 2008;71:1319-1325.
14. Friedman L, Kenny JT, Wise AL, et al. Brain activation during silent word generation evaluated with functional MRI. Brain Lang 1998;64:231-256.
15. Phelps EA, Hyder F, Blamire AM, Shulman RG. FMRI of the prefrontal cortex during overt verbal fluency. Neuroreport 1997;8:561-565.
16. Woermann FG, Jokeit H, Luerding R, et al. Language lateralization by Wada test and fMRI in 100 patients with epilepsy. Neurology 2003;61:699-701.
17. Owen AM, McMillan KM, Laird AR, Bullmore E. N-back working memory paradigm: a meta-analysis of normative functional neuroimaging studies. Hum Brain Mapp 2005;25:46-59.
18. Coull JT. Neural correlates of attention and arousal: insights from electrophysiology, functional neuroimaging and psy-chopharmacology. Prog Neurobiol 1998;55:343-361.
19. Binder JR, Desai RH, Graves WW, Conant LL. Where is the semantic system? A critical review and meta-analysis of 120 functional neuroimaging studies. Cereb Cortex 2009; 19:2767-2796.
20. Raichle ME, MacLeod AM, Snyder AZ, Powers WJ, Gusnard DA, Shulman GL. A default mode of brain function. Proc Natl Acad Sci USA 2001;98:676-682.
21. Seghier ML, Price CJ. Functional heterogeneity within the default network during semantic processing and speech production. Front Psychol 2012;3:281.
22. Andrews-Hanna JR. The brain's default network and its adaptive role in internal mentation. Neuroscientist 2012; 18:251-270.
23. Pulman J, Jette N, Dykeman J, Hemming K, Hutton JL, Marson AG. Topiramate add-on for drug-resistant partial epilepsy. Cochrane Database Syst Rev 2014:CD001417.
24. Carmichael K, Pulman J, Lakhan SE, Parikh P, Marson AG. Zonisamide add-on for drug-resistant partial epilepsy. Cochrane Database Syst Rev 2013:CD001416.
25. Mbizvo GK, Dixon P, Hutton JL, Marson AG. Levetir-acetam add-on for drug-resistant focal epilepsy: an updated Cochrane review. Cochrane Database Syst Rev 2012: CD001901.
26. Witt J-A, Elger CE, Helmstaedter C. Adverse cognitive effects of antiepileptic pharmacotherapy: each additional drug matters. Eur Neuropsychopharmacol 2015;25: 1954-1959.
27. Duncan JS, Winston GP, Koepp MJ, Ourselin S. Brain imaging in the assessment for epilepsy surgery. Lancet Neurol 2016;15:420-433.